Correlation Between Mediantechn and Acticor Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mediantechn and Acticor Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mediantechn and Acticor Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mediantechn and Acticor Biotech SAS, you can compare the effects of market volatilities on Mediantechn and Acticor Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mediantechn with a short position of Acticor Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mediantechn and Acticor Biotech.

Diversification Opportunities for Mediantechn and Acticor Biotech

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Mediantechn and Acticor is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mediantechn and Acticor Biotech SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acticor Biotech SAS and Mediantechn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mediantechn are associated (or correlated) with Acticor Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acticor Biotech SAS has no effect on the direction of Mediantechn i.e., Mediantechn and Acticor Biotech go up and down completely randomly.

Pair Corralation between Mediantechn and Acticor Biotech

Assuming the 90 days trading horizon Mediantechn is expected to generate 1.05 times more return on investment than Acticor Biotech. However, Mediantechn is 1.05 times more volatile than Acticor Biotech SAS. It trades about -0.18 of its potential returns per unit of risk. Acticor Biotech SAS is currently generating about -0.27 per unit of risk. If you would invest  425.00  in Mediantechn on September 14, 2024 and sell it today you would lose (80.00) from holding Mediantechn or give up 18.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mediantechn  vs.  Acticor Biotech SAS

 Performance 
       Timeline  
Mediantechn 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mediantechn has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Acticor Biotech SAS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Mediantechn and Acticor Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mediantechn and Acticor Biotech

The main advantage of trading using opposite Mediantechn and Acticor Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mediantechn position performs unexpectedly, Acticor Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acticor Biotech will offset losses from the drop in Acticor Biotech's long position.
The idea behind Mediantechn and Acticor Biotech SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios